Skip Navigation

Link to  the National Institutes of Health  
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Archives of the National Institute on Drug Abuse web site
Go to the Home page
   

Home > Newsroom > Note to Editors    

NIDA to Take Part in National Inhalants & Poison Awareness Week - Institute Recently Announced New Inhalants Research Initiative


For Immediate Release

The National Institute on Drug Abuse (NIDA), National Institutes of Health, will participate in a press conference on Thursday, March 14, at 9:30 a.m. to kick-off the 10th Annual National Inhalants and Poisons Awareness Week (NIPAW), March 17 - 23, 2002. To coincide with the 2002 NIPAW, NIDA has produced two informational post cards featuring graphics from the National Inhalant Prevention Coalition website, courtesy of GSD&M, and is distributing 12,500 copies of these free in surf, ski, and skate shops nationwide. These shops reach younger teen audiences.

NIDA also has recently launched a new inhalants research initiative, Inhalant Abuse: Supporting Broad-Based Research Approaches, to intensify its research efforts on the epidemiology, social, behavioral, cognitive, and neurobiological consequences of inhalant abuse, as well as treatment and prevention. Findings from this research initiative will enhance NIDA's understanding of inhalant abuse and shape the Institute's public information efforts in this area.

NIDA now reaches middle schoolers with Mind Over Matter, a 7-part series including a segment on inhalants that encourages young people to learn about the neurobiological effects of drugs; and reaches older English and Spanish audiences with the Research Report series and the NIDA Infofax on Inhalants. All of these materials can be downloaded from NIDA's website, www.drugabuse.gov.


National Inhalants & Poison Awareness Week News Conference

WHEN: Thursday, March 14, 2002, at 9:30 A.M.
WHERE: National Press Club, First Amendment Room
14th and F Streets NW
Washington, D.C.
WHO: Featured at the press briefing will be:
John P. Walters, Director, White House Office of National Drug Control Policy (ONDCP)
Charles G. Curie, MA, ACSW, Administrator, SAMHSA
H. Westley Clark, MD, JD, MPH, Director of CSAT
David Shurtleff, PhD, Acting Director, Division of Neuroscience & Behavioral Research, National Institute on Drug Abuse (NIDA)
Elaine Parry, Acting Deputy Director of the Center for Substance Abuse Prevention (CSAP)
Harvey Weiss, MBA, Executive Director of the National Inhalant Prevention Coalition
Stephen J. Pasierb, Partnership for a Drug Free America
Joan and Megan Hakeman, a mother and her daughter who is in recovery from inhalant abuse
Laurie Culp, a mother whose son died from using inhalants

The press conference is coordinated by the Substance Abuse and Mental Health Services Administration's Center for Substance Abuse Treatment.


The National Institute on Drug Abuse is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports more than 85 percent of the world's research on the health aspects of drug abuse and addiction. The Institute carries out a large variety of programs to ensure the rapid dissemination of research information and its implementation in policy and practice. Fact sheets on the health effects of drugs of abuse and other topics can be ordered free of charge in English and Spanish by calling NIDA Infofax at 1-888-NIH-NIDA (644-6432) or 1-888-TTY-NIDA (889-6432) for the deaf. These fact sheets and further information on NIDA research and other activities can be found on the Home page at http://www.drugabuse.gov.




For more information about any item in this Release:

  • Michelle Muth Person
    or Blair Gately:
    301-443-6245


Archive Home | Accessibility | Privacy | FOIA (NIH) | Current NIDA Home Page
National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. . The U.S. government's official web portal